Renal Artery Revascularization
Open Access
- 1 November 2014
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 174 (11) , 1849-1851
Abstract
Arguments for renal artery revascularization include blood pressure control, stabilization of renal function, and reduction in adverse cardiovascular events. We previously reported on the randomized clinical trial data to 2009 regarding renal artery revascularization compared with medical therapy.1 That report concluded that renal artery revascularization was associated with marginal improvement in serum creatinine levels (P = .06) and no improvement in systolic blood pressure (P = .32), although there was need for fewer antihypertensive medications (P < .001). Since then, the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) Trial has been published.2Keywords
This publication has 3 references indexed in Scilit:
- Stenting and Medical Therapy for Atherosclerotic Renal-Artery StenosisNew England Journal of Medicine, 2014
- Effect of Renal Artery Stenting on Left Ventricular Mass: A Randomized Clinical TrialAmerican Journal of Kidney Diseases, 2012
- Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: A meta-analysis of randomized controlled trialsAmerican Heart Journal, 2011